Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | estrogen receptor 1 | Starlite/ChEMBL | References |
Homo sapiens | estrogen receptor 2 (ER beta) | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | estrogen receptor 2 (ER beta) | 495 aa | 418 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | glucose 6 phosphate 1 dehydrogenase | 0.0125 | 0.8075 | 0.7857 |
Loa Loa (eye worm) | glucose-6-phosphate dehydrogenase | 0.0125 | 0.8075 | 0.7857 |
Leishmania major | carbonic anhydrase-like protein | 0.0145 | 1 | 1 |
Trichomonas vaginalis | 6-phosphogluconolactonase, putative | 0.0125 | 0.8075 | 0.5 |
Trypanosoma brucei | carbonic anhydrase-like protein | 0.0145 | 1 | 1 |
Mycobacterium tuberculosis | Probable glucose-6-phosphate 1-dehydrogenase Zwf2 (G6PD) | 0.0043 | 0 | 0.5 |
Echinococcus granulosus | carbonic anhydrase II | 0.0145 | 1 | 1 |
Plasmodium falciparum | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0.0125 | 0.8075 | 1 |
Toxoplasma gondii | glucose-6-phosphate 1-dehydrogenase | 0.0125 | 0.8075 | 1 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.0145 | 1 | 1 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.0145 | 1 | 1 |
Brugia malayi | Putative carbonic anhydrase 5 precursor | 0.0145 | 1 | 1 |
Trichomonas vaginalis | glucosamine-6-phosphate isomerase, putative | 0.0125 | 0.8075 | 0.5 |
Loa Loa (eye worm) | carbonic anhydrase 3 | 0.0145 | 1 | 1 |
Giardia lamblia | Glucose-6-phosphate 1-dehydrogenase | 0.0125 | 0.8075 | 0.5 |
Echinococcus multilocularis | carbonic anhydrase II | 0.0145 | 1 | 1 |
Schistosoma mansoni | glucose-6-phosphate 1-dehydrogenase | 0.0125 | 0.8075 | 0.7857 |
Treponema pallidum | glucose-6-phosphate 1-dehydrogenase | 0.0125 | 0.8075 | 0.5 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.0145 | 1 | 1 |
Mycobacterium ulcerans | glucose-6-phosphate 1-dehydrogenase | 0.0125 | 0.8075 | 1 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.0145 | 1 | 1 |
Chlamydia trachomatis | glucose-6-phosphate 1-dehydrogenase | 0.0125 | 0.8075 | 0.5 |
Echinococcus granulosus | glucose 6 phosphate 1 dehydrogenase | 0.0125 | 0.8075 | 0.7857 |
Trichomonas vaginalis | glucosamine-6-phosphate isomerase, putative | 0.0125 | 0.8075 | 0.5 |
Brugia malayi | glucose-6-phosphate dehydrogenase | 0.0125 | 0.8075 | 0.7857 |
Plasmodium vivax | glucose-6-phosphate 1-dehydrogenase, putative | 0.0125 | 0.8075 | 0.5 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.0145 | 1 | 1 |
Toxoplasma gondii | glucose-6-phosphate 1-dehydrogenase | 0.0082 | 0.3786 | 0.3924 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Antagonism (functional) | % | Antagonism of uterine weight gain in immature rats after 1 mg/kg subcutaneous administration; ND denotes not determined | ChEMBL. | 15125925 |
Antagonism (functional) | 0 % | Antagonism of uterine weight gain in immature rats after 1 mg/kg subcutaneous administration; ND denotes not determined | ChEMBL. | 15125925 |
CL (ADMET) | = 51 ml min-1 kg-1 | Plasma clearance of the compund in female SpragueDawley rats | ChEMBL. | 15125925 |
Estrogenic effect (functional) | % | Estrogenic effect on uterine weight gain in immature rats after 1 mg/kg subcutaneous administration; ND denotes not determined | ChEMBL. | 15125925 |
Estrogenic effect (functional) | 0 % | Estrogenic effect on uterine weight gain in immature rats after 1 mg/kg subcutaneous administration; ND denotes not determined | ChEMBL. | 15125925 |
F (ADMET) | = 6 % | Bioavailability in rat (Sprague-Dawley) (female) | ChEMBL. | 15125925 |
IC50 (binding) | = 2 nM | Displacement of [3H]-17-beta-estradiol from full length human estrogen receptor alpha | ChEMBL. | 15125925 |
IC50 (binding) | = 2 nM | Displacement of [3H]-17-beta-estradiol from full length human estrogen receptor alpha | ChEMBL. | 15125925 |
IC50 (functional) | = 5.5 nM | Potency in cellular transactivation assay utilizing HEK-293 cells stably co-transfected with human estrogen receptor alpha and the alkaline phosphatase reporter gene. | ChEMBL. | 15125925 |
IC50 (functional) | = 5.5 nM | Potency in cellular transactivation assay utilizing HEK-293 cells stably co-transfected with human estrogen receptor alpha and the alkaline phosphatase reporter gene. | ChEMBL. | 15125925 |
IC50 (binding) | = 46.2 nM | Displacement of [3H]-17-beta-estradiol from full length human estrogen receptor beta | ChEMBL. | 15125925 |
IC50 (binding) | = 46.2 nM | Displacement of [3H]-17-beta-estradiol from full length human estrogen receptor beta | ChEMBL. | 15125925 |
IC50 (functional) | = 199.8 nM | Potency in cellular transactivation assay utilizing HEK-293 cells stably co-transfected with human estrogen receptor beta and the alkaline phosphatase reporter gene | ChEMBL. | 15125925 |
IC50 (functional) | = 199.8 nM | Potency in cellular transactivation assay utilizing HEK-293 cells stably co-transfected with human estrogen receptor beta and the alkaline phosphatase reporter gene | ChEMBL. | 15125925 |
T1/2 (ADMET) | = 2.7 hr | Half life period of the compound in female SpragueDawley rats | ChEMBL. | 15125925 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.